Vascular Closure With a Device Compared to Manual Compression After Atrial Fibrillation Ablation: The LockeT II Study

Recruiting now · Not applicable

Conditions studied: Atrial Fibrillation, Hemostasis

In brief

The LockeT II study is a single center, prospective randomized study. It is intended to study the effectiveness of using LockeT device to gain hemostasis after venous procedures as compared to Manual Compression (MC). Approximately 110 patients will be enrolled.

Key facts

Study ID
NCT06078735
Run by
Kansas City Heart Rhythm Research Foundation
People needed
110
Starts
2023-10-02
Expected to finish
2024-12-01
Last updated by the study team
2024-10-29

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.